P

Inventor

ZANG JINGWU

CN15 patents
⚠️ This page may combine multiple inventors who share the name “ZANG JINGWU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

I MAB

6 patents
US10059769B2Aug 28, 2018

Anti-PD-L1 antibodies and uses thereof

I MAB15 citations91
US10584169B2Mar 10, 2020

Anti-CD73 antibodies and uses thereof

I MAB11 citations84
US10208119B2Feb 19, 2019

Anti-PD-L1 antibodies and uses thereof

I MAB11 citations82
US10723799B2Jul 28, 2020

Anti-PD-L1 antibodies and uses thereof

I MAB1 citations71
US10577421B2Mar 3, 2020

Anti-LAG-3 antibodies and uses thereof

I MAB3 citations71
US11220546B2Jan 11, 2022

Anti-PD-L1 antibodies and uses thereof

I MAB1 citations61

I MAB BIOPHARMA US LTD

6 patents
US11034771B2Jun 15, 2021

Anti-CD73 anti-PD-L1 bispecific antibodies

I MAB BIOPHARMA US LTD9 citations83
US12091467B2Sep 17, 2024

CD47 monoclonal antibodies and uses thereof

I MAB BIOPHARMA US LTD0 citations61
US11613577B2Mar 28, 2023

Anti-CD73 antibodies and uses thereof

I MAB BIOPHARMA US LTD0 citations61
US11414485B2Aug 16, 2022

Anti-LAG-3 antibodies and uses thereof

I MAB BIOPHARMA US LTD0 citations61
US10973853B2Apr 13, 2021

Antibodies to T cell immunoreceptor with IG and ITIM domains (TIGIT) and uses thereof

I MAB BIOPHARMA US LTD0 citations59
US11401331B2Aug 2, 2022

Anti-PD-L1 antibody and IL-7 fusions

I MAB BIOPHARMA US LTD1 citations58

I MAB BIOPHARMA CO LTD

2 patents
US10647767B2May 12, 2020

Anti-GM-CSF antibodies and uses thereof

I MAB BIOPHARMA CO LTD1 citations68
US10889641B2Jan 12, 2021

Anti-GM-CSF antibodies and uses thereof

I MAB BIOPHARMA CO LTD0 citations58

I MAB BIOPHARMA HANGZHOU CO LTD

1 patent
US11926662B2Mar 12, 2024

Anti-GM-CSF antibodies and uses thereof

I MAB BIOPHARMA HANGZHOU CO LTD1 citations66